SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Morhed Elisabeth)
 

Search: WFRF:(Morhed Elisabeth) > Outcome in a prospe...

  • Baumann, PiaKarolinska Institutet (author)

Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy.

  • Article/chapterEnglish2009

Publisher, publication year, extent ...

  • 2009

Numbers

  • LIBRIS-ID:oai:gup.ub.gu.se/109142
  • https://gup.ub.gu.se/publication/109142URI
  • https://doi.org/10.1200/JCO.2008.21.5681DOI
  • https://lup.lub.lu.se/record/1412692URI
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-254513URI
  • http://kipublications.ki.se/Default.aspx?queryparsed=id:119053523URI
  • https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-20169URI

Supplementary language notes

  • Language:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • PURPOSE: The impact of stereotactic body radiotherapy (SBRT) on 3-year progression-free survival of medically inoperable patients with stage I non-small-cell lung cancer (NSCLC) was analyzed in a prospective phase II study. PATIENTS AND METHODS: Fifty-seven patients with T1NOMO (70%) and T2N0M0 (30%) were included between August 2003 and September 2005 at seven different centers in Sweden, Norway, and Denmark and observed up to 36 months. SBRT was delivered with 15 Gy times three at the 67% isodose of the planning target volume. RESULTS: Progression-free survival at 3 years was 52%. Overall- and cancer-specific survival at 1, 2, and 3 years was 86%, 65%, 60%, and 93%, 88%, 88%, respectively. There was no statistically significant difference in survival between patients with T1 or T2 tumors. At a median follow-up of 35 months (range, 4 to 47 months), 27 patients (47%) were deceased, seven as a result of lung cancer and 20 as a result of concurrent disease. Kaplan-Meier estimated local control at 3 years was 92%. Local relapse was observed in four patients (7%). Regional relapse was observed in three patients (5%). Nine patients (16%) developed distant metastases. The estimated risk of all failure (local, regional, or distant metastases) was increased in patients with T2 (41%) compared with those with T1 (18%) tumors (P = .027). CONCLUSION: With a 3-year local tumor control rate higher than 90% with limited toxicity, SBRT emerges as state-of-the-art treatment for medically inoperable stage I NSCLC and may even challenge surgery in operable instances.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Nyman, Jan,1956 (author)
  • Hoyer, Morten (author)
  • Wennberg, BeritKarolinska Institutet (author)
  • Gagliardi, GiovannaKarolinska Institutet (author)
  • Lax, IngmarKarolinska Institutet (author)
  • Drugge, NinniGothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper,Institute of Clinical Sciences (author)
  • Ekberg, Lars (author)
  • Friesland, SigneKarolinska Institutet (author)
  • Johansson, Karl-AxelGothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper,Institute of Clinical Sciences (author)
  • Lund, Jo-Asmund (author)
  • Morhed, Elisabeth (author)
  • Nilsson, Kristina,1967-Uppsala universitet,Experimentell och klinisk onkologi(Swepub:uu)kristnil (author)
  • Levin, Nina (author)
  • Paludan, Merete (author)
  • Sederholm, ChristerÖstergötlands Läns Landsting,Linköpings universitet,Lungmedicin,Hälsouniversitetet,Lungmedicinska kliniken US(Swepub:liu)chrse81 (author)
  • Traberg, Anders (author)
  • Wittgren, LenaLund University,Lunds universitet,Institutionen för kliniska vetenskaper, Malmö,Medicinska fakulteten,Department of Clinical Sciences, Malmö,Faculty of Medicine(Swepub:lu)rfa-lwi (author)
  • Lewensohn, RolfKarolinska Institutet (author)
  • Karolinska InstitutetInstitutionen för kliniska vetenskaper (creator_code:org_t)

Related titles

  • In:Journal of clinical oncology : official journal of the American Society of Clinical Oncology27:20, s. 3290-61527-77550732-183X

Internet link

Find in a library

To the university's database

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view